During the past decade, Central Research Associates, Inc. conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 21 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 21 clinical trials were completed. i.e. 161.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Research Associates, Inc." #1 sponsor was "MiMedx Group, Inc." with 6 trials, followed by "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "AOBiome LLC" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Research Associates, Inc." #1 collaborator was "Veristat, Inc." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Central Research Associates, Inc." are "Knee Osteoarthritis" (4 trials), "Osteoarthritis, Knee" (3 trials), "Hot Flashes" (2 trials), "Knee Arthritis" (2 trials) and "Knee Pain Chronic" (2 trials). Many other conditions were trialed in "Central Research Associates, Inc." in a lesser frequency.

Most popular intervention types in "Central Research Associates, Inc." are "Drug" (28 trials), "Biological" (14 trials), "Other" (8 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Saline" (3 trials), "B244" (2 trials), "Fenofibrate" (2 trials) and "K-877" (2 trials). Other intervention names were less common.

The vast majority of trials in "Central Research Associates, Inc." are 37 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Central Research Associates, Inc.". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Central Research Associates, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Central Research Associates, Inc., 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".